Osteoarticular Infections in Infants Under 3 Months of Age

Detalhes bibliográficos
Autor(a) principal: Branco, J
Data de Publicação: 2022
Outros Autores: Duarte, M, Norte, S, Arcangelo, J, Alves, P, Brito, M, Tavares, D, Gouveia, C
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.17/4508
Resumo: Background: Acute osteoarticular infections (OAI) in infants under 3 months of age (≤3M) are rare and remain a diagnostic challenge. Orthopedic complications and functional sequelae have been less well described in this age group. Our aims were to evaluate trends in aetiology, management, and outcomes of OAI ≤ 3M, and to compare these younger children who have OAI with older children. Methods: A longitudinal observational study was conducted of OAI cases admitted to tertiary care pediatric hospital from 2008 to 2018. OAI ≤ 3M was compared with children above 3 months. Clinical, microbiological, imaging, and outcome data were analyzed. Results: We identified 24 (9.1%) of the 263 OAI in children under 3 months. Analyzing OAI ≤ 3M there was a twofold increase since 2014; 54% were males with a median age of 28 days (IQR: 13.5-60.0), 10 (41.7%) were premature and nine (37.5%) had healthcare-associated infections. Microbiological causes were identified in 87.5%, mostly Staphylococcus aureus (57.1%) and Group B Streptococcus (23.8%), and 25% were multidrug-resistant (5 methicillin-resistant S. aureus and 1 Enterobacter cloacae). Bacteremia (100% vs 36.8%, P = 0.037), multidrug resistant bacteria (75% vs 16, P = 0.04), and healthcare-associated infections (100% vs 26.3%, P = 0.014) were associated with sequelae. Comparing OAI ≤ 3M with older children, OAI ≤ 3M were treated with longer antibiotic courses, had more complications and sequelae (17.4% vs 3.2%, P = 0.002). Conclusions: S. aureus is still the most common cause of OAI ≤ 3M, and 25% of causative bacteria were multidrug-resistant bacteria. Complications and sequelae were more frequent in OAI ≤ 3M when compared with older children.
id RCAP_90fa3787f9c0ba7655c387c6c92f251a
oai_identifier_str oai:repositorio.chlc.min-saude.pt:10400.17/4508
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Osteoarticular Infections in Infants Under 3 Months of AgeAdolescentAnti-Bacterial Agents / therapeutic useBacteremia* / microbiologyChildCross Infection* / drug therapyInfantFemaleMaleMethicillin-Resistant Staphylococcus aureus*Osteomyelitis* / diagnosisOsteomyelitis* / epidemiologyOsteomyelitis* / therapyRetrospective StudiesStaphylococcal Infections* / diagnosisStaphylococcal Infections* / drug therapyStaphylococcal Infections* / epidemiologyStaphylococcus aureusHDE INF PEDHDE ORT PEDHDE IMABackground: Acute osteoarticular infections (OAI) in infants under 3 months of age (≤3M) are rare and remain a diagnostic challenge. Orthopedic complications and functional sequelae have been less well described in this age group. Our aims were to evaluate trends in aetiology, management, and outcomes of OAI ≤ 3M, and to compare these younger children who have OAI with older children. Methods: A longitudinal observational study was conducted of OAI cases admitted to tertiary care pediatric hospital from 2008 to 2018. OAI ≤ 3M was compared with children above 3 months. Clinical, microbiological, imaging, and outcome data were analyzed. Results: We identified 24 (9.1%) of the 263 OAI in children under 3 months. Analyzing OAI ≤ 3M there was a twofold increase since 2014; 54% were males with a median age of 28 days (IQR: 13.5-60.0), 10 (41.7%) were premature and nine (37.5%) had healthcare-associated infections. Microbiological causes were identified in 87.5%, mostly Staphylococcus aureus (57.1%) and Group B Streptococcus (23.8%), and 25% were multidrug-resistant (5 methicillin-resistant S. aureus and 1 Enterobacter cloacae). Bacteremia (100% vs 36.8%, P = 0.037), multidrug resistant bacteria (75% vs 16, P = 0.04), and healthcare-associated infections (100% vs 26.3%, P = 0.014) were associated with sequelae. Comparing OAI ≤ 3M with older children, OAI ≤ 3M were treated with longer antibiotic courses, had more complications and sequelae (17.4% vs 3.2%, P = 0.002). Conclusions: S. aureus is still the most common cause of OAI ≤ 3M, and 25% of causative bacteria were multidrug-resistant bacteria. Complications and sequelae were more frequent in OAI ≤ 3M when compared with older children.WileyRepositório do Centro Hospitalar Universitário de Lisboa Central, EPEBranco, JDuarte, MNorte, SArcangelo, JAlves, PBrito, MTavares, DGouveia, C2023-05-04T11:56:49Z20222022-01-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.17/4508engPediatr Int . 2022 Jan;64(1):e1521210.1111/ped.15212info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-05-07T05:44:25Zoai:repositorio.chlc.min-saude.pt:10400.17/4508Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T17:51:00.230386Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Osteoarticular Infections in Infants Under 3 Months of Age
title Osteoarticular Infections in Infants Under 3 Months of Age
spellingShingle Osteoarticular Infections in Infants Under 3 Months of Age
Branco, J
Adolescent
Anti-Bacterial Agents / therapeutic use
Bacteremia* / microbiology
Child
Cross Infection* / drug therapy
Infant
Female
Male
Methicillin-Resistant Staphylococcus aureus*
Osteomyelitis* / diagnosis
Osteomyelitis* / epidemiology
Osteomyelitis* / therapy
Retrospective Studies
Staphylococcal Infections* / diagnosis
Staphylococcal Infections* / drug therapy
Staphylococcal Infections* / epidemiology
Staphylococcus aureus
HDE INF PED
HDE ORT PED
HDE IMA
title_short Osteoarticular Infections in Infants Under 3 Months of Age
title_full Osteoarticular Infections in Infants Under 3 Months of Age
title_fullStr Osteoarticular Infections in Infants Under 3 Months of Age
title_full_unstemmed Osteoarticular Infections in Infants Under 3 Months of Age
title_sort Osteoarticular Infections in Infants Under 3 Months of Age
author Branco, J
author_facet Branco, J
Duarte, M
Norte, S
Arcangelo, J
Alves, P
Brito, M
Tavares, D
Gouveia, C
author_role author
author2 Duarte, M
Norte, S
Arcangelo, J
Alves, P
Brito, M
Tavares, D
Gouveia, C
author2_role author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Repositório do Centro Hospitalar Universitário de Lisboa Central, EPE
dc.contributor.author.fl_str_mv Branco, J
Duarte, M
Norte, S
Arcangelo, J
Alves, P
Brito, M
Tavares, D
Gouveia, C
dc.subject.por.fl_str_mv Adolescent
Anti-Bacterial Agents / therapeutic use
Bacteremia* / microbiology
Child
Cross Infection* / drug therapy
Infant
Female
Male
Methicillin-Resistant Staphylococcus aureus*
Osteomyelitis* / diagnosis
Osteomyelitis* / epidemiology
Osteomyelitis* / therapy
Retrospective Studies
Staphylococcal Infections* / diagnosis
Staphylococcal Infections* / drug therapy
Staphylococcal Infections* / epidemiology
Staphylococcus aureus
HDE INF PED
HDE ORT PED
HDE IMA
topic Adolescent
Anti-Bacterial Agents / therapeutic use
Bacteremia* / microbiology
Child
Cross Infection* / drug therapy
Infant
Female
Male
Methicillin-Resistant Staphylococcus aureus*
Osteomyelitis* / diagnosis
Osteomyelitis* / epidemiology
Osteomyelitis* / therapy
Retrospective Studies
Staphylococcal Infections* / diagnosis
Staphylococcal Infections* / drug therapy
Staphylococcal Infections* / epidemiology
Staphylococcus aureus
HDE INF PED
HDE ORT PED
HDE IMA
description Background: Acute osteoarticular infections (OAI) in infants under 3 months of age (≤3M) are rare and remain a diagnostic challenge. Orthopedic complications and functional sequelae have been less well described in this age group. Our aims were to evaluate trends in aetiology, management, and outcomes of OAI ≤ 3M, and to compare these younger children who have OAI with older children. Methods: A longitudinal observational study was conducted of OAI cases admitted to tertiary care pediatric hospital from 2008 to 2018. OAI ≤ 3M was compared with children above 3 months. Clinical, microbiological, imaging, and outcome data were analyzed. Results: We identified 24 (9.1%) of the 263 OAI in children under 3 months. Analyzing OAI ≤ 3M there was a twofold increase since 2014; 54% were males with a median age of 28 days (IQR: 13.5-60.0), 10 (41.7%) were premature and nine (37.5%) had healthcare-associated infections. Microbiological causes were identified in 87.5%, mostly Staphylococcus aureus (57.1%) and Group B Streptococcus (23.8%), and 25% were multidrug-resistant (5 methicillin-resistant S. aureus and 1 Enterobacter cloacae). Bacteremia (100% vs 36.8%, P = 0.037), multidrug resistant bacteria (75% vs 16, P = 0.04), and healthcare-associated infections (100% vs 26.3%, P = 0.014) were associated with sequelae. Comparing OAI ≤ 3M with older children, OAI ≤ 3M were treated with longer antibiotic courses, had more complications and sequelae (17.4% vs 3.2%, P = 0.002). Conclusions: S. aureus is still the most common cause of OAI ≤ 3M, and 25% of causative bacteria were multidrug-resistant bacteria. Complications and sequelae were more frequent in OAI ≤ 3M when compared with older children.
publishDate 2022
dc.date.none.fl_str_mv 2022
2022-01-01T00:00:00Z
2023-05-04T11:56:49Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.17/4508
url http://hdl.handle.net/10400.17/4508
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Pediatr Int . 2022 Jan;64(1):e15212
10.1111/ped.15212
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Wiley
publisher.none.fl_str_mv Wiley
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799131588589518848